Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Non Operating Income (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Non Operating Income for 11 consecutive years, with -$4.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 133.95% year-over-year to -$4.3 million, compared with a TTM value of $527000.0 through Dec 2025, down 97.08%, and an annual FY2025 reading of $527000.0, down 96.07% over the prior year.
  • Non Operating Income was -$4.3 million for Q4 2025 at Wave Life Sciences, down from $2.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $12.7 million in Q4 2024 and bottomed at -$4.3 million in Q4 2025.
  • Average Non Operating Income over 5 years is $1.6 million, with a median of $937500.0 recorded in 2021.
  • The sharpest move saw Non Operating Income crashed 192.83% in 2022, then skyrocketed 3805.93% in 2024.
  • Year by year, Non Operating Income stood at $1.1 million in 2021, then tumbled by 192.83% to -$1.0 million in 2022, then skyrocketed by 921.43% to $8.5 million in 2023, then soared by 49.37% to $12.7 million in 2024, then plummeted by 133.95% to -$4.3 million in 2025.
  • Business Quant data shows Non Operating Income for WVE at -$4.3 million in Q4 2025, $2.5 million in Q3 2025, and $2.3 million in Q2 2025.